Trial intelligence / Profile preview

Dermatopharmacokinetic study of LC1702 flurbiprofen tape in healthy males

jRCT2031230393Active, not recruiting

Sponsor
Lead Chemical
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Trial of flurbiprofen (2 arms), sponsored by Lead Chemical. Primary endpoint: Amount of flurbiprofen in the stratum corneum. Started Oct 2023; status: active, not recruiting.

02

Drugs

flurbiprofen

Beyond the preview

Go deeper on jRCT2031230393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2031230393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call